{"id":"https://openalex.org/W4283702525","doi":"https://doi.org/10.1097/inf.0000000000003622","title":"Current Aspects of Pediatric Pharmacokinetics and Pharmacodynamics of Antimicrobials in Japan: Importance of the Promotion of Population PK/PD Analysis","display_name":"Current Aspects of Pediatric Pharmacokinetics and Pharmacodynamics of Antimicrobials in Japan: Importance of the Promotion of Population PK/PD Analysis","publication_year":2022,"publication_date":"2022-06-28","ids":{"openalex":"https://openalex.org/W4283702525","doi":"https://doi.org/10.1097/inf.0000000000003622","pmid":"https://pubmed.ncbi.nlm.nih.gov/35763684"},"language":"en","primary_location":{"id":"doi:10.1097/inf.0000000000003622","doi":"https://doi.org/10.1097/inf.0000000000003622","is_oa":false,"landing_page_url":"https://doi.org/10.1097/inf.0000000000003622","pdf_url":null,"source":{"id":"https://openalex.org/S109369870","display_name":"The Pediatric Infectious Disease Journal","issn_l":"0891-3668","issn":["0891-3668","1532-0987"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pediatric Infectious Disease Journal","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008266188","display_name":"Kensuke Shoji","orcid":"https://orcid.org/0000-0002-7164-0262","observed_orcids":["https://orcid.org/0000-0002-7164-0262"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Kensuke Shoji","raw_affiliation_strings":["Division of Infectious Diseases, Department of Medical Subspecialties"],"raw_orcid":"https://orcid.org/0000-0002-7164-0262","affiliations":[{"raw_affiliation_string":"Division of Infectious Diseases, Department of Medical Subspecialties","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058900236","display_name":"Jumpei Saito","orcid":"https://orcid.org/0000-0003-4799-5562","observed_orcids":["https://orcid.org/0000-0003-4799-5562"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jumpei Saito","raw_affiliation_strings":["Department of Pharmacy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014914035","display_name":"Hidefumi Nakamura","orcid":"https://orcid.org/0000-0003-0191-2450","observed_orcids":["https://orcid.org/0000-0003-0191-2450"]},"institutions":[{"id":"https://openalex.org/I4210132193","display_name":"National Center For Child Health and Development","ror":"https://ror.org/03fvwxc59","country_code":"JP","type":"government","lineage":["https://openalex.org/I4210132193"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hidefumi Nakamura","raw_affiliation_strings":["Department of Research and Development Supervision, National Center for Child Health and Development"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Research and Development Supervision, National Center for Child Health and Development","institution_ids":["https://openalex.org/I4210132193"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029406810","display_name":"Kazuaki Matsumoto","orcid":"https://orcid.org/0000-0002-5462-1684","observed_orcids":["https://orcid.org/0000-0002-5462-1684"]},"institutions":[{"id":"https://openalex.org/I203951103","display_name":"Keio University","ror":"https://ror.org/02kn6nx58","country_code":"JP","type":"education","lineage":["https://openalex.org/I203951103"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazuaki Matsumoto","raw_affiliation_strings":["Division of Pharmacodynamics, Keio University Faculty of Pharmacy, Tokyo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacodynamics, Keio University Faculty of Pharmacy, Tokyo","institution_ids":["https://openalex.org/I203951103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079773896","display_name":"Kazutaka Oda","orcid":"https://orcid.org/0000-0003-0693-1896","observed_orcids":["https://orcid.org/0000-0003-0693-1896"]},"institutions":[{"id":"https://openalex.org/I4210122547","display_name":"Kumamoto University Hospital","ror":"https://ror.org/02vgs9327","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210122547"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazutaka Oda","raw_affiliation_strings":["Department of Pharmacy, Kumamoto University Hospital, Kumamoto"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Kumamoto University Hospital, Kumamoto","institution_ids":["https://openalex.org/I4210122547"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104472974","display_name":"Yoshio Takesue","orcid":"https://orcid.org/0000-0002-8635-6416","observed_orcids":["https://orcid.org/0000-0002-8635-6416"]},"institutions":[{"id":"https://openalex.org/I137459256","display_name":"Hyogo Medical University","ror":"https://ror.org/001yc7927","country_code":"JP","type":"education","lineage":["https://openalex.org/I137459256"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Yoshio Takesue","raw_affiliation_strings":["Department of Clinical Infectious Diseases, Tokoname City Hospital, Tokoname","Department of Infection Prevention and Control, Hyogo College of Medicine, Nishinomiya"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Infectious Diseases, Tokoname City Hospital, Tokoname","institution_ids":[]},{"raw_affiliation_string":"Department of Infection Prevention and Control, Hyogo College of Medicine, Nishinomiya","institution_ids":["https://openalex.org/I137459256"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5032270192","display_name":"Isao Miyairi","orcid":"https://orcid.org/0000-0003-3886-9089","observed_orcids":["https://orcid.org/0000-0003-3886-9089"]},"institutions":[{"id":"https://openalex.org/I3123035732","display_name":"Hamamatsu University School of Medicine","ror":"https://ror.org/00ndx3g44","country_code":"JP","type":"education","lineage":["https://openalex.org/I3123035732"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Isao Miyairi","raw_affiliation_strings":["Department of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan","Division of Infectious Diseases, Department of Medical Subspecialties"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan","institution_ids":["https://openalex.org/I3123035732"]},{"raw_affiliation_string":"Division of Infectious Diseases, Department of Medical Subspecialties","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5008266188","https://openalex.org/A5032270192","https://openalex.org/A5104472974"],"corresponding_institution_ids":["https://openalex.org/I137459256","https://openalex.org/I3123035732"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"41","issue":"10","first_page":"e418","last_page":"e423"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.736299991607666,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.736299991607666,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.2615000009536743,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pediatric-pharmacokinetics","display_name":"pediatric pharmacokinetics","score":0.9940000176429749},{"id":"https://openalex.org/keywords/pediatric-pharmacodynamics","display_name":"pediatric pharmacodynamics","score":0.9359999895095825},{"id":"https://openalex.org/keywords/antimicrobial-agents","display_name":"antimicrobial agents","score":0.8849999904632568},{"id":"https://openalex.org/keywords/individualized-dosing","display_name":"individualized dosing","score":0.9039999842643738},{"id":"https://openalex.org/keywords/children","display_name":"children","score":0.34299999475479126},{"id":"https://openalex.org/keywords/japan","display_name":"Japan","score":0.5640000104904175}],"concepts":[{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.7936142086982727},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.776108980178833},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7008107900619507},{"id":"https://openalex.org/C4937899","wikidata":"https://www.wikidata.org/wiki/Q68541106","display_name":"Antimicrobial","level":2,"score":0.6296402812004089},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5790979862213135},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5727535486221313},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.5382506847381592},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5131953358650208},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.07997742295265198},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000890","descriptor_name":"Anti-Infective Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000890","descriptor_name":"Anti-Infective Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007564","descriptor_name":"Japan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/inf.0000000000003622","doi":"https://doi.org/10.1097/inf.0000000000003622","is_oa":false,"landing_page_url":"https://doi.org/10.1097/inf.0000000000003622","pdf_url":null,"source":{"id":"https://openalex.org/S109369870","display_name":"The Pediatric Infectious Disease Journal","issn_l":"0891-3668","issn":["0891-3668","1532-0987"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pediatric Infectious Disease Journal","raw_type":"journal-article"},{"id":"pmid:35763684","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35763684","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Pediatric infectious disease journal","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G6186952198","display_name":"Progression of antimicrobial therapy against antimicrobial resistance innovated by maximized therapeutic effect of beta-lactams.","funder_award_id":"20K17467","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"}],"funders":[{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":46,"referenced_works":["https://openalex.org/W2005551936","https://openalex.org/W2022046755","https://openalex.org/W2067409569","https://openalex.org/W2071918548","https://openalex.org/W2122527560","https://openalex.org/W2254880446","https://openalex.org/W2495444602","https://openalex.org/W2510513174","https://openalex.org/W2586337928","https://openalex.org/W2604296510","https://openalex.org/W2865806885","https://openalex.org/W2892958770","https://openalex.org/W2929478224","https://openalex.org/W2937820719","https://openalex.org/W2940092795","https://openalex.org/W2945465453","https://openalex.org/W2954496304","https://openalex.org/W2976079483","https://openalex.org/W2977900162","https://openalex.org/W3016422745","https://openalex.org/W3025255261","https://openalex.org/W3032895330","https://openalex.org/W3041660845","https://openalex.org/W3045083407","https://openalex.org/W3068359810","https://openalex.org/W3092783549","https://openalex.org/W3099053731","https://openalex.org/W3108046233","https://openalex.org/W3108236901","https://openalex.org/W3111752688","https://openalex.org/W3114258541","https://openalex.org/W3126782185","https://openalex.org/W3127099261","https://openalex.org/W3128512023","https://openalex.org/W3147291971","https://openalex.org/W3153037053","https://openalex.org/W3190415248","https://openalex.org/W3203265145","https://openalex.org/W3203526787","https://openalex.org/W3206492921","https://openalex.org/W3217673112","https://openalex.org/W4205345677","https://openalex.org/W4213318376","https://openalex.org/W4213414504","https://openalex.org/W4220854678","https://openalex.org/W6600288106"],"related_works":["https://openalex.org/W4391490963","https://openalex.org/W2027265786","https://openalex.org/W4211020845","https://openalex.org/W1970580273","https://openalex.org/W2595258872","https://openalex.org/W636563923","https://openalex.org/W7124671903","https://openalex.org/W2021319218","https://openalex.org/W2358171503","https://openalex.org/W1785847611"],"abstract_inverted_index":{"Pharmacologic":[0],"knowledge":[1],"is":[2,61,65,88],"important":[3,62],"for":[4,82,100],"pediatricians":[5],"conducting":[6,25],"feasible":[7],"pharmacokinetic":[8],"or":[9,13],"pharmacodynamic":[10],"(PK/PD)":[11],"studies":[12,27,73,115],"applying":[14],"effective":[15],"antimicrobial":[16,30],"therapies":[17],"in":[18,24,28,33,40,74,91,118],"children.":[19],"Because":[20],"of":[21,43,46,112,116,130],"the":[22,41,92,109,128],"difficulties":[23],"PK/PD":[26,31,48,72,83,86,114,132],"children,":[29],"data":[32,57,81],"children":[34,75],"are":[35],"still":[36],"limited.":[37],"To":[38],"fill":[39],"lack":[42],"knowledge,":[44],"promotion":[45],"population":[47,131],"analysis,":[49],"which":[50],"allows":[51],"us":[52],"to":[53,70,95],"handle":[54],"sparse":[55],"sampling":[56],"from":[58,120],"individual":[59],"patients,":[60],"because":[63],"it":[64],"considered":[66],"a":[67],"suitable":[68],"methodology":[69],"conduct":[71],"with":[76,103],"limited":[77],"blood":[78],"drug":[79],"concentration":[80],"analysis.":[84,133],"Population":[85],"analysis":[87],"also":[89],"useful":[90],"clinical":[93,121],"setting":[94],"provide":[96],"individualized":[97],"optimal":[98],"dosage":[99],"each":[101],"patient":[102],"various":[104],"conditions.":[105],"Here":[106],"we":[107],"summarized":[108],"current":[110],"aspects":[111],"pediatric":[113],"antimicrobials":[117],"Japan":[119],"and":[122],"research":[123],"perspectives,":[124],"specifically":[125],"focusing":[126],"on":[127],"importance":[129]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-06-30T00:00:00"}